 Phuong Le
Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 12 | 2025 | 562 | 1.910 |
Why?
| | Neoplastic Stem Cells | 6 | 2020 | 409 | 0.960 |
Why?
| | Carcinoma, Squamous Cell | 8 | 2019 | 644 | 0.940 |
Why?
| | Papillomaviridae | 3 | 2025 | 116 | 0.920 |
Why?
| | Wnt Signaling Pathway | 2 | 2018 | 210 | 0.850 |
Why?
| | Cell Culture Techniques | 1 | 2025 | 373 | 0.750 |
Why?
| | Papillomavirus Infections | 2 | 2025 | 343 | 0.680 |
Why?
| | Cell Communication | 1 | 2018 | 326 | 0.490 |
Why?
| | Tumor Microenvironment | 2 | 2020 | 737 | 0.440 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2014 | 41 | 0.410 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2014 | 231 | 0.360 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 667 | 0.350 |
Why?
| | Xenograft Model Antitumor Assays | 9 | 2025 | 929 | 0.340 |
Why?
| | Cell Line, Tumor | 8 | 2025 | 3537 | 0.260 |
Why?
| | Antineoplastic Agents | 3 | 2016 | 2207 | 0.260 |
Why?
| | Melanoma | 2 | 2025 | 759 | 0.240 |
Why?
| | Cancer-Associated Fibroblasts | 1 | 2025 | 23 | 0.230 |
Why?
| | Coculture Techniques | 1 | 2025 | 246 | 0.210 |
Why?
| | Thymus Gland | 1 | 2025 | 311 | 0.210 |
Why?
| | Hedgehog Proteins | 3 | 2015 | 200 | 0.210 |
Why?
| | Organoids | 1 | 2025 | 144 | 0.200 |
Why?
| | Mice, Nude | 4 | 2018 | 678 | 0.200 |
Why?
| | Hyaluronan Receptors | 2 | 2020 | 105 | 0.190 |
Why?
| | Flow Cytometry | 1 | 2025 | 1156 | 0.170 |
Why?
| | B7-H1 Antigen | 1 | 2023 | 243 | 0.170 |
Why?
| | Mice | 13 | 2025 | 18338 | 0.170 |
Why?
| | Cetuximab | 3 | 2015 | 111 | 0.160 |
Why?
| | SOXB1 Transcription Factors | 2 | 2020 | 67 | 0.160 |
Why?
| | Tumor Cells, Cultured | 2 | 2018 | 883 | 0.150 |
Why?
| | Animals | 16 | 2025 | 38141 | 0.150 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2020 | 48 | 0.150 |
Why?
| | Stem Cell Niche | 1 | 2019 | 57 | 0.150 |
Why?
| | Mouth Neoplasms | 1 | 2019 | 90 | 0.140 |
Why?
| | Neoplasms | 1 | 2014 | 2897 | 0.140 |
Why?
| | Peptides, Cyclic | 1 | 2020 | 275 | 0.140 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2018 | 57 | 0.130 |
Why?
| | Salivary Gland Neoplasms | 1 | 2018 | 39 | 0.130 |
Why?
| | T-Lymphocytes | 1 | 2025 | 1996 | 0.130 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 505 | 0.130 |
Why?
| | Veratrum Alkaloids | 2 | 2014 | 20 | 0.120 |
Why?
| | Cell Proliferation | 3 | 2019 | 2499 | 0.120 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2013 | 994 | 0.120 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 24 | 0.120 |
Why?
| | Disease Models, Animal | 4 | 2020 | 4559 | 0.120 |
Why?
| | ErbB Receptors | 3 | 2016 | 635 | 0.120 |
Why?
| | Immunotherapy | 1 | 2020 | 667 | 0.110 |
Why?
| | Hematopoietic Stem Cells | 1 | 2018 | 419 | 0.110 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 1965 | 0.110 |
Why?
| | Replication Protein A | 1 | 2014 | 14 | 0.100 |
Why?
| | DNA-Activated Protein Kinase | 1 | 2014 | 14 | 0.100 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2014 | 44 | 0.100 |
Why?
| | Stromal Cells | 1 | 2014 | 120 | 0.100 |
Why?
| | Homologous Recombination | 1 | 2014 | 37 | 0.100 |
Why?
| | Radiation Tolerance | 1 | 2014 | 103 | 0.100 |
Why?
| | Humans | 18 | 2025 | 145491 | 0.100 |
Why?
| | Immunophenotyping | 3 | 2019 | 320 | 0.100 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2020 | 1150 | 0.100 |
Why?
| | Leukemia, Radiation-Induced | 1 | 2012 | 4 | 0.090 |
Why?
| | Sulfones | 1 | 2013 | 127 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 2 | 2013 | 620 | 0.090 |
Why?
| | Microsatellite Instability | 1 | 2012 | 55 | 0.090 |
Why?
| | Gamma Rays | 1 | 2012 | 57 | 0.090 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2018 | 700 | 0.090 |
Why?
| | Glycine | 1 | 2013 | 186 | 0.090 |
Why?
| | DNA Replication | 1 | 2014 | 252 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1439 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1321 | 0.080 |
Why?
| | Mice, Inbred NOD | 2 | 2023 | 613 | 0.080 |
Why?
| | Apoptosis | 1 | 2018 | 2411 | 0.080 |
Why?
| | Trans-Activators | 1 | 2012 | 397 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2020 | 380 | 0.080 |
Why?
| | Nuclear Proteins | 1 | 2014 | 743 | 0.070 |
Why?
| | Immunohistochemistry | 3 | 2019 | 1710 | 0.070 |
Why?
| | Signal Transduction | 4 | 2016 | 5202 | 0.070 |
Why?
| | RNA, Messenger | 1 | 2016 | 2820 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 2 | 2020 | 140 | 0.060 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2012 | 686 | 0.060 |
Why?
| | Antigens, Neoplasm | 1 | 2025 | 272 | 0.050 |
Why?
| | Mutation | 4 | 2018 | 4093 | 0.050 |
Why?
| | Cell Cycle Proteins | 2 | 2020 | 631 | 0.050 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 272 | 0.050 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2016 | 452 | 0.040 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2023 | 264 | 0.040 |
Why?
| | Zinc Finger E-box-Binding Homeobox 1 | 1 | 2020 | 21 | 0.040 |
Why?
| | Feedback, Physiological | 1 | 2020 | 81 | 0.040 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2020 | 18 | 0.040 |
Why?
| | Radiotherapy Dosage | 1 | 2020 | 288 | 0.040 |
Why?
| | Heterografts | 1 | 2019 | 143 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2020 | 225 | 0.030 |
Why?
| | Chemoradiotherapy | 1 | 2020 | 239 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 169 | 0.030 |
Why?
| | Monocytes | 1 | 2020 | 536 | 0.030 |
Why?
| | Biomarkers | 2 | 2019 | 4283 | 0.030 |
Why?
| | Female | 6 | 2025 | 78763 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 426 | 0.030 |
Why?
| | DNA Repair | 1 | 2020 | 256 | 0.030 |
Why?
| | DNA Damage | 1 | 2020 | 434 | 0.030 |
Why?
| | Retinal Dehydrogenase | 1 | 2016 | 29 | 0.030 |
Why?
| | Cell Cycle | 1 | 2020 | 595 | 0.030 |
Why?
| | Neoplasm Transplantation | 1 | 2016 | 246 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2018 | 227 | 0.030 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2016 | 99 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 74 | 0.030 |
Why?
| | Maximum Tolerated Dose | 1 | 2015 | 211 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1468 | 0.030 |
Why?
| | Cadherins | 1 | 2016 | 200 | 0.030 |
Why?
| | Cell Division | 1 | 2016 | 753 | 0.030 |
Why?
| | Zinc Finger Protein GLI1 | 1 | 2014 | 26 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 36 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 1142 | 0.030 |
Why?
| | Checkpoint Kinase 1 | 1 | 2014 | 27 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2016 | 337 | 0.030 |
Why?
| | Cricetulus | 1 | 2014 | 115 | 0.030 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2014 | 68 | 0.030 |
Why?
| | CHO Cells | 1 | 2014 | 166 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 443 | 0.030 |
Why?
| | Cricetinae | 1 | 2014 | 299 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 771 | 0.030 |
Why?
| | Serine | 1 | 2014 | 144 | 0.020 |
Why?
| | Receptor, Notch2 | 1 | 2013 | 15 | 0.020 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.020 |
Why?
| | Gonanes | 1 | 2013 | 23 | 0.020 |
Why?
| | Antigens, CD | 1 | 2016 | 557 | 0.020 |
Why?
| | Alphapapillomavirus | 1 | 2013 | 35 | 0.020 |
Why?
| | Linear Energy Transfer | 1 | 2012 | 4 | 0.020 |
Why?
| | Cesium Radioisotopes | 1 | 2012 | 4 | 0.020 |
Why?
| | Receptor, Notch1 | 1 | 2013 | 63 | 0.020 |
Why?
| | Chromatids | 1 | 2012 | 10 | 0.020 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2014 | 211 | 0.020 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 108 | 0.020 |
Why?
| | Mice, Inbred CBA | 1 | 2012 | 57 | 0.020 |
Why?
| | Protein Kinases | 1 | 2014 | 314 | 0.020 |
Why?
| | Gene Silencing | 1 | 2013 | 202 | 0.020 |
Why?
| | Chromosome Aberrations | 1 | 2012 | 164 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 848 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2012 | 324 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2018 | 3125 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1769 | 0.020 |
Why?
| | Gene Expression | 1 | 2015 | 1478 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 1162 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2862 | 0.020 |
Why?
| | Iron | 1 | 2012 | 359 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1896 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 1038 | 0.020 |
Why?
| | Male | 4 | 2020 | 72817 | 0.020 |
Why?
| | Phosphorylation | 1 | 2014 | 1707 | 0.020 |
Why?
| | Single-Cell Analysis | 1 | 2012 | 359 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 687 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2013 | 881 | 0.020 |
Why?
| | Transcription Factors | 1 | 2014 | 1733 | 0.010 |
Why?
| | Middle Aged | 2 | 2019 | 36176 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2015 | 11831 | 0.010 |
Why?
| | Aged | 1 | 2019 | 26125 | 0.010 |
Why?
|
|
Le's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|